RELATED CONTENT
NEWS
- SkyePharma secures Sanofi deal for Flutiform
- Supreme Court justices question lack of Bayh-Dole rules for assigning rights
- EU reprieve for Actos as CHMP concludes benefits outweigh risks in selected patients
- AMAG, Allos to merge – but will it really bring sales synergies for Feraheme, Folotyn?


